Alpelisib Completed Phase 1 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02088684Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer